Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Darling

Showing results (241-250 of 268) with videos related to

Pageof 27
Sort By:
Biorxiv : the Preprint Server for Biology|May 13, 2022
The highly conserved stem-loop II motif is important for the lifecycle of astroviruses but dispensable for SARS-CoV-2Andrew B Janowski, Hongbing Jiang, Chika Fujii, et al.
ACS Chemical Biology|June 13, 2018
Targeting the FKBP51/GR/Hsp90 Complex to Identify Functionally Relevant Treatments for Depression and PTSDJonathan J Sabbagh, Ricardo A Cordova, Dali Zheng, et al.
Journal of Virology|May 24, 2023
The Highly Conserved Stem-Loop II Motif Is Dispensable for SARS-CoV-2Hongbing Jiang, Astha Joshi, Tianyu Gan, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamstersTraci L Bricker, Tamarand L Darling, Ahmed O Hassan, et al.
Cell Reports|July 10, 2021
A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamstersTraci L Bricker, Tamarand L Darling, Ahmed O Hassan, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
The highly conserved stem-loop II motif is dispensable for SARS-CoV-2Hongbing Jiang, Astha Joshi, Tianyu Gan, et al.
Med (New York, N.Y.)|May 18, 2022
mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2Tamarand L Darling, Baoling Ying, Bradley Whitener, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Antigenic characterization of SARS-CoV-2 variants BA.3.2.1 and BA.3.2.2 in three animal modelsSamuel A Turner, Joey Olivier, Madison L Ellis, et al.
Nature Communications|July 4, 2023
An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivoMoriya Tsuji, Manoj S Nair, Kazuya Masuda, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protectionEmma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Pageof 27

Showing results (241-250 of 268) with videos related to

Sort By:
Pageof 27
Biorxiv : the Preprint Server for Biology|May 13, 2022
The highly conserved stem-loop II motif is important for the lifecycle of astroviruses but dispensable for SARS-CoV-2Andrew B Janowski, Hongbing Jiang, Chika Fujii, et al.
ACS Chemical Biology|June 13, 2018
Targeting the FKBP51/GR/Hsp90 Complex to Identify Functionally Relevant Treatments for Depression and PTSDJonathan J Sabbagh, Ricardo A Cordova, Dali Zheng, et al.
Journal of Virology|May 24, 2023
The Highly Conserved Stem-Loop II Motif Is Dispensable for SARS-CoV-2Hongbing Jiang, Astha Joshi, Tianyu Gan, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamstersTraci L Bricker, Tamarand L Darling, Ahmed O Hassan, et al.
Cell Reports|July 10, 2021
A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamstersTraci L Bricker, Tamarand L Darling, Ahmed O Hassan, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
The highly conserved stem-loop II motif is dispensable for SARS-CoV-2Hongbing Jiang, Astha Joshi, Tianyu Gan, et al.
Med (New York, N.Y.)|May 18, 2022
mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2Tamarand L Darling, Baoling Ying, Bradley Whitener, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Antigenic characterization of SARS-CoV-2 variants BA.3.2.1 and BA.3.2.2 in three animal modelsSamuel A Turner, Joey Olivier, Madison L Ellis, et al.
Nature Communications|July 4, 2023
An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivoMoriya Tsuji, Manoj S Nair, Kazuya Masuda, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protectionEmma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Pageof 27